nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B1—breast cancer	0.26	0.555	CbGaD
Olmesartan—AGTR1—breast cancer	0.209	0.445	CbGaD
Olmesartan—SLCO1B3—Paclitaxel—breast cancer	0.0467	0.151	CbGbCtD
Olmesartan—SLCO1B3—Docetaxel—breast cancer	0.0338	0.109	CbGbCtD
Olmesartan—ABCC2—Tamoxifen—breast cancer	0.0307	0.099	CbGbCtD
Olmesartan—SLCO1B1—Irinotecan—breast cancer	0.0269	0.0865	CbGbCtD
Olmesartan—SLCO1B3—Methotrexate—breast cancer	0.0244	0.0786	CbGbCtD
Olmesartan—ABCC2—Paclitaxel—breast cancer	0.0239	0.077	CbGbCtD
Olmesartan—ABCC2—Irinotecan—breast cancer	0.0236	0.076	CbGbCtD
Olmesartan—ABCC2—Carboplatin—breast cancer	0.0225	0.0725	CbGbCtD
Olmesartan—ABCC2—Vinblastine—breast cancer	0.021	0.0676	CbGbCtD
Olmesartan—ABCC2—Docetaxel—breast cancer	0.0173	0.0557	CbGbCtD
Olmesartan—SLCO1B1—Methotrexate—breast cancer	0.0142	0.0458	CbGbCtD
Olmesartan—ABCC2—Doxorubicin—breast cancer	0.0129	0.0415	CbGbCtD
Olmesartan—ABCC2—Methotrexate—breast cancer	0.0125	0.0402	CbGbCtD
Olmesartan—Tasosartan—AGTR2—breast cancer	0.00092	0.181	CrCbGaD
Olmesartan—SLCO1B1—mammary gland—breast cancer	0.000751	0.124	CbGeAlD
Olmesartan—AGTR1—nipple—breast cancer	0.000651	0.107	CbGeAlD
Olmesartan—SLCO1B3—pituitary gland—breast cancer	0.000587	0.0965	CbGeAlD
Olmesartan—Azilsartan medoxomil—AGTR1—breast cancer	0.000566	0.111	CrCbGaD
Olmesartan—Forasartan—AGTR1—breast cancer	0.000526	0.103	CrCbGaD
Olmesartan—SLCO1B3—endocrine gland—breast cancer	0.000454	0.0748	CbGeAlD
Olmesartan—AGTR1—epithelium—breast cancer	0.000438	0.0721	CbGeAlD
Olmesartan—AGTR1—pituitary gland—breast cancer	0.000356	0.0585	CbGeAlD
Olmesartan—AGTR1—adipose tissue—breast cancer	0.000354	0.0583	CbGeAlD
Olmesartan—Valsartan—SLCO1B1—breast cancer	0.000345	0.0677	CrCbGaD
Olmesartan—Irbesartan—JUN—breast cancer	0.000338	0.0664	CrCbGaD
Olmesartan—AGTR1—female reproductive system—breast cancer	0.000326	0.0536	CbGeAlD
Olmesartan—Tasosartan—AGTR1—breast cancer	0.000319	0.0626	CrCbGaD
Olmesartan—AGTR1—adrenal gland—breast cancer	0.000318	0.0523	CbGeAlD
Olmesartan—SLCO1B1—female reproductive system—breast cancer	0.000311	0.0511	CbGeAlD
Olmesartan—Valsartan—AGTR1—breast cancer	0.000276	0.0543	CrCbGaD
Olmesartan—AGTR1—endocrine gland—breast cancer	0.000276	0.0453	CbGeAlD
Olmesartan—SLCO1B1—endocrine gland—breast cancer	0.000263	0.0432	CbGeAlD
Olmesartan—Telmisartan—AGTR1—breast cancer	0.00026	0.0511	CrCbGaD
Olmesartan—ABCC2—female reproductive system—breast cancer	0.000235	0.0387	CbGeAlD
Olmesartan—ABCC2—adrenal gland—breast cancer	0.00023	0.0378	CbGeAlD
Olmesartan—Candesartan—AGTR1—breast cancer	0.00021	0.0412	CrCbGaD
Olmesartan—Irbesartan—AGTR1—breast cancer	0.00021	0.0412	CrCbGaD
Olmesartan—ABCC2—endocrine gland—breast cancer	0.000199	0.0328	CbGeAlD
Olmesartan—AGTR1—lymph node—breast cancer	0.000191	0.0313	CbGeAlD
Olmesartan—Losartan—SLCO1B1—breast cancer	0.000168	0.0331	CrCbGaD
Olmesartan—Telmisartan—ABCG2—breast cancer	0.000141	0.0277	CrCbGaD
Olmesartan—ABCC2—lymph node—breast cancer	0.000138	0.0227	CbGeAlD
Olmesartan—Losartan—AGTR1—breast cancer	0.000135	0.0265	CrCbGaD
Olmesartan—Irbesartan—PTGS1—breast cancer	9.74e-05	0.0191	CrCbGaD
Olmesartan—Candesartan—PTGS1—breast cancer	9.74e-05	0.0191	CrCbGaD
Olmesartan—Tasosartan—CYP3A4—breast cancer	8.65e-05	0.017	CrCbGaD
Olmesartan—Irbesartan—CYP2D6—breast cancer	6.63e-05	0.013	CrCbGaD
Olmesartan—Valsartan—ALB—breast cancer	6.55e-05	0.0129	CrCbGaD
Olmesartan—Telmisartan—ABCB1—breast cancer	5.87e-05	0.0115	CrCbGaD
Olmesartan—Irbesartan—CYP3A4—breast cancer	5.69e-05	0.0112	CrCbGaD
Olmesartan—Candesartan—ABCB1—breast cancer	4.73e-05	0.0093	CrCbGaD
Olmesartan—Losartan—CYP3A4—breast cancer	3.66e-05	0.0072	CrCbGaD
Olmesartan—Connective tissue disorder—Epirubicin—breast cancer	3.21e-05	0.000216	CcSEcCtD
Olmesartan—Abdominal pain—Paclitaxel—breast cancer	3.2e-05	0.000216	CcSEcCtD
Olmesartan—Body temperature increased—Paclitaxel—breast cancer	3.2e-05	0.000216	CcSEcCtD
Olmesartan—Urethral disorder—Epirubicin—breast cancer	3.2e-05	0.000215	CcSEcCtD
Olmesartan—Losartan—ALB—breast cancer	3.2e-05	0.00628	CrCbGaD
Olmesartan—Anorexia—Capecitabine—breast cancer	3.17e-05	0.000213	CcSEcCtD
Olmesartan—Angiopathy—Methotrexate—breast cancer	3.16e-05	0.000213	CcSEcCtD
Olmesartan—Vomiting—Mitoxantrone—breast cancer	3.16e-05	0.000213	CcSEcCtD
Olmesartan—Vomiting—Irinotecan—breast cancer	3.16e-05	0.000213	CcSEcCtD
Olmesartan—Sinusitis—Doxorubicin—breast cancer	3.15e-05	0.000212	CcSEcCtD
Olmesartan—Dizziness—Fluorouracil—breast cancer	3.15e-05	0.000212	CcSEcCtD
Olmesartan—Mediastinal disorder—Methotrexate—breast cancer	3.14e-05	0.000211	CcSEcCtD
Olmesartan—Agranulocytosis—Doxorubicin—breast cancer	3.14e-05	0.000211	CcSEcCtD
Olmesartan—Rash—Mitoxantrone—breast cancer	3.13e-05	0.000211	CcSEcCtD
Olmesartan—Rash—Irinotecan—breast cancer	3.13e-05	0.000211	CcSEcCtD
Olmesartan—Dermatitis—Irinotecan—breast cancer	3.13e-05	0.000211	CcSEcCtD
Olmesartan—Dermatitis—Mitoxantrone—breast cancer	3.13e-05	0.000211	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Docetaxel—breast cancer	3.13e-05	0.000211	CcSEcCtD
Olmesartan—Headache—Mitoxantrone—breast cancer	3.11e-05	0.00021	CcSEcCtD
Olmesartan—Headache—Irinotecan—breast cancer	3.11e-05	0.00021	CcSEcCtD
Olmesartan—Hypotension—Capecitabine—breast cancer	3.11e-05	0.000209	CcSEcCtD
Olmesartan—Insomnia—Docetaxel—breast cancer	3.11e-05	0.000209	CcSEcCtD
Olmesartan—Alopecia—Methotrexate—breast cancer	3.08e-05	0.000207	CcSEcCtD
Olmesartan—Vomiting—Gemcitabine—breast cancer	3.08e-05	0.000207	CcSEcCtD
Olmesartan—Mental disorder—Methotrexate—breast cancer	3.05e-05	0.000206	CcSEcCtD
Olmesartan—Rash—Gemcitabine—breast cancer	3.05e-05	0.000205	CcSEcCtD
Olmesartan—Losartan—ABCB1—breast cancer	3.05e-05	0.00599	CrCbGaD
Olmesartan—Dermatitis—Gemcitabine—breast cancer	3.05e-05	0.000205	CcSEcCtD
Olmesartan—Malnutrition—Methotrexate—breast cancer	3.03e-05	0.000204	CcSEcCtD
Olmesartan—Headache—Gemcitabine—breast cancer	3.03e-05	0.000204	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Capecitabine—breast cancer	3.03e-05	0.000204	CcSEcCtD
Olmesartan—Vomiting—Fluorouracil—breast cancer	3.03e-05	0.000204	CcSEcCtD
Olmesartan—Rhinitis—Doxorubicin—breast cancer	3.03e-05	0.000204	CcSEcCtD
Olmesartan—Dyspepsia—Docetaxel—breast cancer	3.02e-05	0.000204	CcSEcCtD
Olmesartan—Insomnia—Capecitabine—breast cancer	3.01e-05	0.000202	CcSEcCtD
Olmesartan—Rash—Fluorouracil—breast cancer	3e-05	0.000202	CcSEcCtD
Olmesartan—Dermatitis—Fluorouracil—breast cancer	3e-05	0.000202	CcSEcCtD
Olmesartan—Pharyngitis—Doxorubicin—breast cancer	3e-05	0.000202	CcSEcCtD
Olmesartan—Decreased appetite—Docetaxel—breast cancer	2.99e-05	0.000201	CcSEcCtD
Olmesartan—Headache—Fluorouracil—breast cancer	2.98e-05	0.000201	CcSEcCtD
Olmesartan—Urinary tract disorder—Doxorubicin—breast cancer	2.98e-05	0.000201	CcSEcCtD
Olmesartan—Oedema peripheral—Doxorubicin—breast cancer	2.97e-05	0.0002	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Docetaxel—breast cancer	2.97e-05	0.0002	CcSEcCtD
Olmesartan—Connective tissue disorder—Doxorubicin—breast cancer	2.97e-05	0.0002	CcSEcCtD
Olmesartan—Fatigue—Docetaxel—breast cancer	2.96e-05	0.000199	CcSEcCtD
Olmesartan—Angiopathy—Epirubicin—breast cancer	2.96e-05	0.000199	CcSEcCtD
Olmesartan—Urethral disorder—Doxorubicin—breast cancer	2.96e-05	0.000199	CcSEcCtD
Olmesartan—Nausea—Irinotecan—breast cancer	2.95e-05	0.000199	CcSEcCtD
Olmesartan—Nausea—Mitoxantrone—breast cancer	2.95e-05	0.000199	CcSEcCtD
Olmesartan—Mediastinal disorder—Epirubicin—breast cancer	2.94e-05	0.000198	CcSEcCtD
Olmesartan—Constipation—Docetaxel—breast cancer	2.94e-05	0.000198	CcSEcCtD
Olmesartan—Pain—Docetaxel—breast cancer	2.94e-05	0.000198	CcSEcCtD
Olmesartan—Back pain—Methotrexate—breast cancer	2.94e-05	0.000198	CcSEcCtD
Olmesartan—Dyspepsia—Capecitabine—breast cancer	2.93e-05	0.000197	CcSEcCtD
Olmesartan—Arrhythmia—Epirubicin—breast cancer	2.91e-05	0.000196	CcSEcCtD
Olmesartan—Asthenia—Paclitaxel—breast cancer	2.91e-05	0.000196	CcSEcCtD
Olmesartan—Decreased appetite—Capecitabine—breast cancer	2.89e-05	0.000195	CcSEcCtD
Olmesartan—Alopecia—Epirubicin—breast cancer	2.88e-05	0.000194	CcSEcCtD
Olmesartan—Nausea—Gemcitabine—breast cancer	2.88e-05	0.000194	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Capecitabine—breast cancer	2.87e-05	0.000193	CcSEcCtD
Olmesartan—Fatigue—Capecitabine—breast cancer	2.87e-05	0.000193	CcSEcCtD
Olmesartan—Pruritus—Paclitaxel—breast cancer	2.87e-05	0.000193	CcSEcCtD
Olmesartan—Vision blurred—Methotrexate—breast cancer	2.86e-05	0.000192	CcSEcCtD
Olmesartan—Mental disorder—Epirubicin—breast cancer	2.86e-05	0.000192	CcSEcCtD
Olmesartan—Constipation—Capecitabine—breast cancer	2.84e-05	0.000191	CcSEcCtD
Olmesartan—Pain—Capecitabine—breast cancer	2.84e-05	0.000191	CcSEcCtD
Olmesartan—Malnutrition—Epirubicin—breast cancer	2.84e-05	0.000191	CcSEcCtD
Olmesartan—Feeling abnormal—Docetaxel—breast cancer	2.83e-05	0.000191	CcSEcCtD
Olmesartan—Nausea—Fluorouracil—breast cancer	2.83e-05	0.00019	CcSEcCtD
Olmesartan—Ill-defined disorder—Methotrexate—breast cancer	2.82e-05	0.000189	CcSEcCtD
Olmesartan—Gastrointestinal pain—Docetaxel—breast cancer	2.81e-05	0.000189	CcSEcCtD
Olmesartan—Anaemia—Methotrexate—breast cancer	2.8e-05	0.000189	CcSEcCtD
Olmesartan—Diarrhoea—Paclitaxel—breast cancer	2.77e-05	0.000187	CcSEcCtD
Olmesartan—Back pain—Epirubicin—breast cancer	2.75e-05	0.000185	CcSEcCtD
Olmesartan—Feeling abnormal—Capecitabine—breast cancer	2.74e-05	0.000184	CcSEcCtD
Olmesartan—Angiopathy—Doxorubicin—breast cancer	2.74e-05	0.000184	CcSEcCtD
Olmesartan—Malaise—Methotrexate—breast cancer	2.74e-05	0.000184	CcSEcCtD
Olmesartan—Muscle spasms—Epirubicin—breast cancer	2.73e-05	0.000184	CcSEcCtD
Olmesartan—Vertigo—Methotrexate—breast cancer	2.73e-05	0.000183	CcSEcCtD
Olmesartan—Gastrointestinal pain—Capecitabine—breast cancer	2.72e-05	0.000183	CcSEcCtD
Olmesartan—Mediastinal disorder—Doxorubicin—breast cancer	2.72e-05	0.000183	CcSEcCtD
Olmesartan—Abdominal pain—Docetaxel—breast cancer	2.72e-05	0.000183	CcSEcCtD
Olmesartan—Body temperature increased—Docetaxel—breast cancer	2.72e-05	0.000183	CcSEcCtD
Olmesartan—Leukopenia—Methotrexate—breast cancer	2.72e-05	0.000183	CcSEcCtD
Olmesartan—Arrhythmia—Doxorubicin—breast cancer	2.7e-05	0.000181	CcSEcCtD
Olmesartan—Dizziness—Paclitaxel—breast cancer	2.68e-05	0.00018	CcSEcCtD
Olmesartan—Vision blurred—Epirubicin—breast cancer	2.68e-05	0.00018	CcSEcCtD
Olmesartan—Alopecia—Doxorubicin—breast cancer	2.67e-05	0.00018	CcSEcCtD
Olmesartan—Cough—Methotrexate—breast cancer	2.65e-05	0.000178	CcSEcCtD
Olmesartan—Mental disorder—Doxorubicin—breast cancer	2.64e-05	0.000178	CcSEcCtD
Olmesartan—Urticaria—Capecitabine—breast cancer	2.64e-05	0.000178	CcSEcCtD
Olmesartan—Ill-defined disorder—Epirubicin—breast cancer	2.63e-05	0.000177	CcSEcCtD
Olmesartan—Abdominal pain—Capecitabine—breast cancer	2.63e-05	0.000177	CcSEcCtD
Olmesartan—Body temperature increased—Capecitabine—breast cancer	2.63e-05	0.000177	CcSEcCtD
Olmesartan—Malnutrition—Doxorubicin—breast cancer	2.63e-05	0.000177	CcSEcCtD
Olmesartan—Anaemia—Epirubicin—breast cancer	2.62e-05	0.000177	CcSEcCtD
Olmesartan—Agitation—Epirubicin—breast cancer	2.61e-05	0.000176	CcSEcCtD
Olmesartan—Myalgia—Methotrexate—breast cancer	2.58e-05	0.000174	CcSEcCtD
Olmesartan—Arthralgia—Methotrexate—breast cancer	2.58e-05	0.000174	CcSEcCtD
Olmesartan—Chest pain—Methotrexate—breast cancer	2.58e-05	0.000174	CcSEcCtD
Olmesartan—Vomiting—Paclitaxel—breast cancer	2.58e-05	0.000173	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.57e-05	0.000173	CcSEcCtD
Olmesartan—Malaise—Epirubicin—breast cancer	2.56e-05	0.000172	CcSEcCtD
Olmesartan—Rash—Paclitaxel—breast cancer	2.56e-05	0.000172	CcSEcCtD
Olmesartan—Dermatitis—Paclitaxel—breast cancer	2.55e-05	0.000172	CcSEcCtD
Olmesartan—Discomfort—Methotrexate—breast cancer	2.55e-05	0.000172	CcSEcCtD
Olmesartan—Vertigo—Epirubicin—breast cancer	2.55e-05	0.000172	CcSEcCtD
Olmesartan—Syncope—Epirubicin—breast cancer	2.55e-05	0.000171	CcSEcCtD
Olmesartan—Leukopenia—Epirubicin—breast cancer	2.54e-05	0.000171	CcSEcCtD
Olmesartan—Back pain—Doxorubicin—breast cancer	2.54e-05	0.000171	CcSEcCtD
Olmesartan—Headache—Paclitaxel—breast cancer	2.54e-05	0.000171	CcSEcCtD
Olmesartan—Muscle spasms—Doxorubicin—breast cancer	2.53e-05	0.00017	CcSEcCtD
Olmesartan—Palpitations—Epirubicin—breast cancer	2.51e-05	0.000169	CcSEcCtD
Olmesartan—Loss of consciousness—Epirubicin—breast cancer	2.5e-05	0.000168	CcSEcCtD
Olmesartan—Cough—Epirubicin—breast cancer	2.48e-05	0.000167	CcSEcCtD
Olmesartan—Anaphylactic shock—Methotrexate—breast cancer	2.48e-05	0.000167	CcSEcCtD
Olmesartan—Vision blurred—Doxorubicin—breast cancer	2.48e-05	0.000167	CcSEcCtD
Olmesartan—Asthenia—Docetaxel—breast cancer	2.47e-05	0.000166	CcSEcCtD
Olmesartan—Infection—Methotrexate—breast cancer	2.46e-05	0.000166	CcSEcCtD
Olmesartan—Ill-defined disorder—Doxorubicin—breast cancer	2.44e-05	0.000164	CcSEcCtD
Olmesartan—Pruritus—Docetaxel—breast cancer	2.43e-05	0.000164	CcSEcCtD
Olmesartan—Nervous system disorder—Methotrexate—breast cancer	2.43e-05	0.000163	CcSEcCtD
Olmesartan—Anaemia—Doxorubicin—breast cancer	2.43e-05	0.000163	CcSEcCtD
Olmesartan—Thrombocytopenia—Methotrexate—breast cancer	2.42e-05	0.000163	CcSEcCtD
Olmesartan—Myalgia—Epirubicin—breast cancer	2.42e-05	0.000163	CcSEcCtD
Olmesartan—Arthralgia—Epirubicin—breast cancer	2.42e-05	0.000163	CcSEcCtD
Olmesartan—Chest pain—Epirubicin—breast cancer	2.42e-05	0.000163	CcSEcCtD
Olmesartan—Agitation—Doxorubicin—breast cancer	2.41e-05	0.000163	CcSEcCtD
Olmesartan—Anxiety—Epirubicin—breast cancer	2.41e-05	0.000162	CcSEcCtD
Olmesartan—Nausea—Paclitaxel—breast cancer	2.41e-05	0.000162	CcSEcCtD
Olmesartan—Skin disorder—Methotrexate—breast cancer	2.41e-05	0.000162	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.4e-05	0.000162	CcSEcCtD
Olmesartan—Hyperhidrosis—Methotrexate—breast cancer	2.39e-05	0.000161	CcSEcCtD
Olmesartan—Discomfort—Epirubicin—breast cancer	2.39e-05	0.000161	CcSEcCtD
Olmesartan—Asthenia—Capecitabine—breast cancer	2.39e-05	0.000161	CcSEcCtD
Olmesartan—Malaise—Doxorubicin—breast cancer	2.37e-05	0.000159	CcSEcCtD
Olmesartan—Vertigo—Doxorubicin—breast cancer	2.36e-05	0.000159	CcSEcCtD
Olmesartan—Anorexia—Methotrexate—breast cancer	2.36e-05	0.000159	CcSEcCtD
Olmesartan—Syncope—Doxorubicin—breast cancer	2.36e-05	0.000159	CcSEcCtD
Olmesartan—Pruritus—Capecitabine—breast cancer	2.35e-05	0.000158	CcSEcCtD
Olmesartan—Leukopenia—Doxorubicin—breast cancer	2.35e-05	0.000158	CcSEcCtD
Olmesartan—Diarrhoea—Docetaxel—breast cancer	2.35e-05	0.000158	CcSEcCtD
Olmesartan—Palpitations—Doxorubicin—breast cancer	2.32e-05	0.000156	CcSEcCtD
Olmesartan—Anaphylactic shock—Epirubicin—breast cancer	2.32e-05	0.000156	CcSEcCtD
Olmesartan—Oedema—Epirubicin—breast cancer	2.32e-05	0.000156	CcSEcCtD
Olmesartan—Hypotension—Methotrexate—breast cancer	2.31e-05	0.000156	CcSEcCtD
Olmesartan—Loss of consciousness—Doxorubicin—breast cancer	2.31e-05	0.000155	CcSEcCtD
Olmesartan—Infection—Epirubicin—breast cancer	2.3e-05	0.000155	CcSEcCtD
Olmesartan—Cough—Doxorubicin—breast cancer	2.29e-05	0.000154	CcSEcCtD
Olmesartan—Shock—Epirubicin—breast cancer	2.28e-05	0.000153	CcSEcCtD
Olmesartan—Diarrhoea—Capecitabine—breast cancer	2.28e-05	0.000153	CcSEcCtD
Olmesartan—Nervous system disorder—Epirubicin—breast cancer	2.27e-05	0.000153	CcSEcCtD
Olmesartan—Dizziness—Docetaxel—breast cancer	2.27e-05	0.000153	CcSEcCtD
Olmesartan—Thrombocytopenia—Epirubicin—breast cancer	2.27e-05	0.000153	CcSEcCtD
Olmesartan—Tachycardia—Epirubicin—breast cancer	2.26e-05	0.000152	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methotrexate—breast cancer	2.26e-05	0.000152	CcSEcCtD
Olmesartan—Skin disorder—Epirubicin—breast cancer	2.25e-05	0.000152	CcSEcCtD
Olmesartan—Hyperhidrosis—Epirubicin—breast cancer	2.24e-05	0.000151	CcSEcCtD
Olmesartan—Insomnia—Methotrexate—breast cancer	2.24e-05	0.000151	CcSEcCtD
Olmesartan—Myalgia—Doxorubicin—breast cancer	2.24e-05	0.000151	CcSEcCtD
Olmesartan—Chest pain—Doxorubicin—breast cancer	2.24e-05	0.000151	CcSEcCtD
Olmesartan—Arthralgia—Doxorubicin—breast cancer	2.24e-05	0.000151	CcSEcCtD
Olmesartan—Anxiety—Doxorubicin—breast cancer	2.23e-05	0.00015	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.22e-05	0.00015	CcSEcCtD
Olmesartan—Discomfort—Doxorubicin—breast cancer	2.21e-05	0.000149	CcSEcCtD
Olmesartan—Anorexia—Epirubicin—breast cancer	2.21e-05	0.000149	CcSEcCtD
Olmesartan—Dizziness—Capecitabine—breast cancer	2.2e-05	0.000148	CcSEcCtD
Olmesartan—Vomiting—Docetaxel—breast cancer	2.18e-05	0.000147	CcSEcCtD
Olmesartan—Dyspepsia—Methotrexate—breast cancer	2.18e-05	0.000147	CcSEcCtD
Olmesartan—Rash—Docetaxel—breast cancer	2.17e-05	0.000146	CcSEcCtD
Olmesartan—Hypotension—Epirubicin—breast cancer	2.17e-05	0.000146	CcSEcCtD
Olmesartan—Dermatitis—Docetaxel—breast cancer	2.16e-05	0.000146	CcSEcCtD
Olmesartan—Decreased appetite—Methotrexate—breast cancer	2.15e-05	0.000145	CcSEcCtD
Olmesartan—Headache—Docetaxel—breast cancer	2.15e-05	0.000145	CcSEcCtD
Olmesartan—Anaphylactic shock—Doxorubicin—breast cancer	2.14e-05	0.000144	CcSEcCtD
Olmesartan—Oedema—Doxorubicin—breast cancer	2.14e-05	0.000144	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Methotrexate—breast cancer	2.14e-05	0.000144	CcSEcCtD
Olmesartan—Fatigue—Methotrexate—breast cancer	2.14e-05	0.000144	CcSEcCtD
Olmesartan—Infection—Doxorubicin—breast cancer	2.13e-05	0.000143	CcSEcCtD
Olmesartan—Pain—Methotrexate—breast cancer	2.12e-05	0.000143	CcSEcCtD
Olmesartan—Vomiting—Capecitabine—breast cancer	2.12e-05	0.000142	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Epirubicin—breast cancer	2.11e-05	0.000142	CcSEcCtD
Olmesartan—Shock—Doxorubicin—breast cancer	2.11e-05	0.000142	CcSEcCtD
Olmesartan—Nervous system disorder—Doxorubicin—breast cancer	2.1e-05	0.000142	CcSEcCtD
Olmesartan—Thrombocytopenia—Doxorubicin—breast cancer	2.1e-05	0.000141	CcSEcCtD
Olmesartan—Rash—Capecitabine—breast cancer	2.1e-05	0.000141	CcSEcCtD
Olmesartan—Insomnia—Epirubicin—breast cancer	2.1e-05	0.000141	CcSEcCtD
Olmesartan—Dermatitis—Capecitabine—breast cancer	2.1e-05	0.000141	CcSEcCtD
Olmesartan—Tachycardia—Doxorubicin—breast cancer	2.09e-05	0.000141	CcSEcCtD
Olmesartan—Headache—Capecitabine—breast cancer	2.08e-05	0.00014	CcSEcCtD
Olmesartan—Skin disorder—Doxorubicin—breast cancer	2.08e-05	0.00014	CcSEcCtD
Olmesartan—Hyperhidrosis—Doxorubicin—breast cancer	2.07e-05	0.00014	CcSEcCtD
Olmesartan—Anorexia—Doxorubicin—breast cancer	2.04e-05	0.000138	CcSEcCtD
Olmesartan—Nausea—Docetaxel—breast cancer	2.04e-05	0.000137	CcSEcCtD
Olmesartan—Feeling abnormal—Methotrexate—breast cancer	2.04e-05	0.000137	CcSEcCtD
Olmesartan—Dyspepsia—Epirubicin—breast cancer	2.04e-05	0.000137	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methotrexate—breast cancer	2.03e-05	0.000136	CcSEcCtD
Olmesartan—Decreased appetite—Epirubicin—breast cancer	2.01e-05	0.000136	CcSEcCtD
Olmesartan—Hypotension—Doxorubicin—breast cancer	2e-05	0.000135	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Epirubicin—breast cancer	2e-05	0.000135	CcSEcCtD
Olmesartan—Fatigue—Epirubicin—breast cancer	2e-05	0.000134	CcSEcCtD
Olmesartan—Pain—Epirubicin—breast cancer	1.98e-05	0.000133	CcSEcCtD
Olmesartan—Constipation—Epirubicin—breast cancer	1.98e-05	0.000133	CcSEcCtD
Olmesartan—Nausea—Capecitabine—breast cancer	1.98e-05	0.000133	CcSEcCtD
Olmesartan—Urticaria—Methotrexate—breast cancer	1.97e-05	0.000132	CcSEcCtD
Olmesartan—Abdominal pain—Methotrexate—breast cancer	1.96e-05	0.000132	CcSEcCtD
Olmesartan—Body temperature increased—Methotrexate—breast cancer	1.96e-05	0.000132	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.95e-05	0.000131	CcSEcCtD
Olmesartan—Insomnia—Doxorubicin—breast cancer	1.94e-05	0.000131	CcSEcCtD
Olmesartan—Feeling abnormal—Epirubicin—breast cancer	1.91e-05	0.000129	CcSEcCtD
Olmesartan—Gastrointestinal pain—Epirubicin—breast cancer	1.9e-05	0.000128	CcSEcCtD
Olmesartan—Dyspepsia—Doxorubicin—breast cancer	1.89e-05	0.000127	CcSEcCtD
Olmesartan—Decreased appetite—Doxorubicin—breast cancer	1.86e-05	0.000125	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Doxorubicin—breast cancer	1.85e-05	0.000125	CcSEcCtD
Olmesartan—Fatigue—Doxorubicin—breast cancer	1.85e-05	0.000124	CcSEcCtD
Olmesartan—Urticaria—Epirubicin—breast cancer	1.84e-05	0.000124	CcSEcCtD
Olmesartan—Constipation—Doxorubicin—breast cancer	1.83e-05	0.000123	CcSEcCtD
Olmesartan—Pain—Doxorubicin—breast cancer	1.83e-05	0.000123	CcSEcCtD
Olmesartan—Abdominal pain—Epirubicin—breast cancer	1.83e-05	0.000123	CcSEcCtD
Olmesartan—Body temperature increased—Epirubicin—breast cancer	1.83e-05	0.000123	CcSEcCtD
Olmesartan—Asthenia—Methotrexate—breast cancer	1.78e-05	0.00012	CcSEcCtD
Olmesartan—Feeling abnormal—Doxorubicin—breast cancer	1.77e-05	0.000119	CcSEcCtD
Olmesartan—Gastrointestinal pain—Doxorubicin—breast cancer	1.75e-05	0.000118	CcSEcCtD
Olmesartan—Pruritus—Methotrexate—breast cancer	1.75e-05	0.000118	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—HMMR—breast cancer	1.72e-05	0.000285	CbGpPWpGaD
Olmesartan—Urticaria—Doxorubicin—breast cancer	1.7e-05	0.000115	CcSEcCtD
Olmesartan—Abdominal pain—Doxorubicin—breast cancer	1.7e-05	0.000114	CcSEcCtD
Olmesartan—Body temperature increased—Doxorubicin—breast cancer	1.7e-05	0.000114	CcSEcCtD
Olmesartan—Diarrhoea—Methotrexate—breast cancer	1.69e-05	0.000114	CcSEcCtD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ABCB1—breast cancer	1.69e-05	0.00028	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ACHE—breast cancer	1.69e-05	0.000279	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTT1—breast cancer	1.69e-05	0.000279	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARGC1B—breast cancer	1.67e-05	0.000276	CbGpPWpGaD
Olmesartan—Asthenia—Epirubicin—breast cancer	1.66e-05	0.000112	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—NOTCH4—breast cancer	1.66e-05	0.000274	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.66e-05	0.000274	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GZMB—breast cancer	1.65e-05	0.000272	CbGpPWpGaD
Olmesartan—Pruritus—Epirubicin—breast cancer	1.64e-05	0.00011	CcSEcCtD
Olmesartan—Dizziness—Methotrexate—breast cancer	1.64e-05	0.00011	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.62e-05	0.000268	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.62e-05	0.000268	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL2—breast cancer	1.6e-05	0.000265	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AGTR2—breast cancer	1.6e-05	0.000265	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP17A1—breast cancer	1.6e-05	0.000264	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—breast cancer	1.59e-05	0.000263	CbGpPWpGaD
Olmesartan—Diarrhoea—Epirubicin—breast cancer	1.59e-05	0.000107	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—ENO1—breast cancer	1.58e-05	0.000262	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS1—breast cancer	1.58e-05	0.000262	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTHLH—breast cancer	1.58e-05	0.000262	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BMP2—breast cancer	1.58e-05	0.000262	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.58e-05	0.000261	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTA4—breast cancer	1.57e-05	0.00026	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CA9—breast cancer	1.57e-05	0.00026	CbGpPWpGaD
Olmesartan—Vomiting—Methotrexate—breast cancer	1.57e-05	0.000106	CcSEcCtD
Olmesartan—Rash—Methotrexate—breast cancer	1.56e-05	0.000105	CcSEcCtD
Olmesartan—Dermatitis—Methotrexate—breast cancer	1.56e-05	0.000105	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.56e-05	0.000257	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.55e-05	0.000257	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2D6—breast cancer	1.55e-05	0.000257	CbGpPWpGaD
Olmesartan—Headache—Methotrexate—breast cancer	1.55e-05	0.000104	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.54e-05	0.000254	CbGpPWpGaD
Olmesartan—Asthenia—Doxorubicin—breast cancer	1.54e-05	0.000104	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—GSTA2—breast cancer	1.53e-05	0.000254	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GPX2—breast cancer	1.53e-05	0.000254	CbGpPWpGaD
Olmesartan—Dizziness—Epirubicin—breast cancer	1.53e-05	0.000103	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—EDNRB—breast cancer	1.53e-05	0.000253	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NCOA2—breast cancer	1.52e-05	0.000252	CbGpPWpGaD
Olmesartan—Pruritus—Doxorubicin—breast cancer	1.52e-05	0.000102	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—PGR—breast cancer	1.52e-05	0.000251	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GPX4—breast cancer	1.52e-05	0.000251	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SULT1A1—breast cancer	1.52e-05	0.000251	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—THBS1—breast cancer	1.51e-05	0.00025	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—breast cancer	1.48e-05	0.000245	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTA1—breast cancer	1.48e-05	0.000245	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—IDH1—breast cancer	1.48e-05	0.000245	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—FASN—breast cancer	1.48e-05	0.000244	CbGpPWpGaD
Olmesartan—Vomiting—Epirubicin—breast cancer	1.47e-05	9.92e-05	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—BCHE—breast cancer	1.47e-05	0.000243	CbGpPWpGaD
Olmesartan—Nausea—Methotrexate—breast cancer	1.47e-05	9.9e-05	CcSEcCtD
Olmesartan—Diarrhoea—Doxorubicin—breast cancer	1.47e-05	9.87e-05	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—NAT2—breast cancer	1.46e-05	0.000242	CbGpPWpGaD
Olmesartan—Rash—Epirubicin—breast cancer	1.46e-05	9.83e-05	CcSEcCtD
Olmesartan—Dermatitis—Epirubicin—breast cancer	1.46e-05	9.83e-05	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—SLC5A5—breast cancer	1.45e-05	0.00024	CbGpPWpGaD
Olmesartan—Headache—Epirubicin—breast cancer	1.45e-05	9.77e-05	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—FLT1—breast cancer	1.44e-05	0.000238	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SQSTM1—breast cancer	1.43e-05	0.000237	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF3—breast cancer	1.43e-05	0.000237	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CG—breast cancer	1.43e-05	0.000236	CbGpPWpGaD
Olmesartan—Dizziness—Doxorubicin—breast cancer	1.42e-05	9.54e-05	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—JAG1—breast cancer	1.42e-05	0.000234	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PARP1—breast cancer	1.41e-05	0.000233	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOTCH3—breast cancer	1.41e-05	0.000233	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NQO1—breast cancer	1.4e-05	0.000232	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC2A1—breast cancer	1.4e-05	0.000232	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CALCA—breast cancer	1.39e-05	0.00023	CbGpPWpGaD
Olmesartan—Nausea—Epirubicin—breast cancer	1.38e-05	9.26e-05	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—RPS6—breast cancer	1.38e-05	0.000228	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.37e-05	0.000227	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP3A4—breast cancer	1.37e-05	0.000226	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF4—breast cancer	1.37e-05	0.000226	CbGpPWpGaD
Olmesartan—Vomiting—Doxorubicin—breast cancer	1.36e-05	9.18e-05	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.36e-05	0.000225	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL12—breast cancer	1.36e-05	0.000225	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCR4—breast cancer	1.36e-05	0.000225	CbGpPWpGaD
Olmesartan—Rash—Doxorubicin—breast cancer	1.35e-05	9.1e-05	CcSEcCtD
Olmesartan—Dermatitis—Doxorubicin—breast cancer	1.35e-05	9.09e-05	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—CYP1B1—breast cancer	1.35e-05	0.000222	CbGpPWpGaD
Olmesartan—Headache—Doxorubicin—breast cancer	1.34e-05	9.04e-05	CcSEcCtD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—RAF1—breast cancer	1.34e-05	0.000221	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PAK1—breast cancer	1.34e-05	0.000221	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.32e-05	0.000219	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HSP90AA1—breast cancer	1.32e-05	0.000218	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TCF7L2—breast cancer	1.31e-05	0.000217	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT2—breast cancer	1.31e-05	0.000216	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CG—breast cancer	1.3e-05	0.000214	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NCOA1—breast cancer	1.28e-05	0.000212	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MED12—breast cancer	1.28e-05	0.000212	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—DPYD—breast cancer	1.28e-05	0.000212	CbGpPWpGaD
Olmesartan—Nausea—Doxorubicin—breast cancer	1.27e-05	8.57e-05	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—STK11—breast cancer	1.27e-05	0.000209	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP19A1—breast cancer	1.27e-05	0.000209	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HSP90AA1—breast cancer	1.26e-05	0.000209	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOTCH2—breast cancer	1.26e-05	0.000209	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALDOA—breast cancer	1.26e-05	0.000209	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CD—breast cancer	1.25e-05	0.000207	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRL—breast cancer	1.23e-05	0.000203	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NCOA3—breast cancer	1.23e-05	0.000203	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC2A2—breast cancer	1.22e-05	0.000201	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADAM10—breast cancer	1.21e-05	0.0002	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STK11—breast cancer	1.21e-05	0.0002	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.21e-05	0.000199	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLG—breast cancer	1.2e-05	0.000198	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CPT1A—breast cancer	1.19e-05	0.000197	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTR—breast cancer	1.19e-05	0.000197	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCG2—breast cancer	1.19e-05	0.000197	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.19e-05	0.000196	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT2—breast cancer	1.19e-05	0.000196	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF10—breast cancer	1.18e-05	0.000195	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—COMT—breast cancer	1.18e-05	0.000194	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTP1—breast cancer	1.17e-05	0.000194	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HPGDS—breast cancer	1.17e-05	0.000193	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HBA1—breast cancer	1.16e-05	0.000192	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HMOX1—breast cancer	1.15e-05	0.000191	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ITPR1—breast cancer	1.15e-05	0.00019	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CD—breast cancer	1.14e-05	0.000188	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PDGFA—breast cancer	1.14e-05	0.000188	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTT1—breast cancer	1.14e-05	0.000188	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ACHE—breast cancer	1.14e-05	0.000188	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFBR2—breast cancer	1.12e-05	0.000185	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCB1—breast cancer	1.11e-05	0.000183	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ITPR1—breast cancer	1.1e-05	0.000183	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP3—breast cancer	1.1e-05	0.000181	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ERBB4—breast cancer	1.1e-05	0.000181	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT5A—breast cancer	1.1e-05	0.000181	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CB—breast cancer	1.09e-05	0.000181	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—TYMS—breast cancer	1.09e-05	0.00018	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NCOR1—breast cancer	1.08e-05	0.000178	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PLA2G4A—breast cancer	1.08e-05	0.000178	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTM1—breast cancer	1.08e-05	0.000178	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP17A1—breast cancer	1.07e-05	0.000178	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ENO1—breast cancer	1.06e-05	0.000176	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS1—breast cancer	1.06e-05	0.000176	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SMAD4—breast cancer	1.06e-05	0.000176	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.06e-05	0.000175	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—breast cancer	1.06e-05	0.000175	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1R—breast cancer	1.06e-05	0.000175	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL8—breast cancer	1.05e-05	0.000174	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.05e-05	0.000173	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2D6—breast cancer	1.04e-05	0.000172	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HES1—breast cancer	1.04e-05	0.000171	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLA2G4A—breast cancer	1.03e-05	0.00017	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NCOR1—breast cancer	1.03e-05	0.00017	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GPX1—breast cancer	1.03e-05	0.00017	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NCOA2—breast cancer	1.02e-05	0.000169	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP1A1—breast cancer	1.02e-05	0.000169	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CSF2—breast cancer	1.02e-05	0.000169	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF1—breast cancer	1.02e-05	0.000169	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—RAF1—breast cancer	1.02e-05	0.000168	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NRG1—breast cancer	1.01e-05	0.000167	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ERCC2—breast cancer	1.01e-05	0.000167	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—H2AFX—breast cancer	1e-05	0.000166	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2—breast cancer	1e-05	0.000166	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—E2F1—breast cancer	9.98e-06	0.000165	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—breast cancer	9.95e-06	0.000164	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CB—breast cancer	9.93e-06	0.000164	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—FASN—breast cancer	9.93e-06	0.000164	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—BCHE—breast cancer	9.89e-06	0.000163	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC5A5—breast cancer	9.77e-06	0.000161	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SPP1—breast cancer	9.59e-06	0.000158	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—RAF1—breast cancer	9.58e-06	0.000158	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL8—breast cancer	9.54e-06	0.000158	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTHFR—breast cancer	9.51e-06	0.000157	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ERBB3—breast cancer	9.48e-06	0.000157	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGFR2—breast cancer	9.47e-06	0.000156	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NQO1—breast cancer	9.43e-06	0.000156	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC2A1—breast cancer	9.43e-06	0.000156	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	9.24e-06	0.000153	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP3A4—breast cancer	9.2e-06	0.000152	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	9.15e-06	0.000151	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2—breast cancer	9.12e-06	0.000151	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TERT—breast cancer	9.09e-06	0.00015	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP1B1—breast cancer	9.04e-06	0.000149	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—RAF1—breast cancer	9e-06	0.000149	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HSP90AA1—breast cancer	8.87e-06	0.000147	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGFR1—breast cancer	8.82e-06	0.000146	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAV1—breast cancer	8.77e-06	0.000145	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HIF1A—breast cancer	8.69e-06	0.000144	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NCOA1—breast cancer	8.63e-06	0.000143	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—STK11—breast cancer	8.5e-06	0.000141	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP19A1—breast cancer	8.5e-06	0.000141	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LEP—breast cancer	8.48e-06	0.00014	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CAV1—breast cancer	8.41e-06	0.000139	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.38e-06	0.000139	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KDR—breast cancer	8.31e-06	0.000137	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ESR1—breast cancer	8.1e-06	0.000134	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FN1—breast cancer	8e-06	0.000132	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CG—breast cancer	7.99e-06	0.000132	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.98e-06	0.000132	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NFKBIA—breast cancer	7.91e-06	0.000131	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—COMT—breast cancer	7.9e-06	0.000131	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTP1—breast cancer	7.87e-06	0.00013	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOTCH1—breast cancer	7.83e-06	0.000129	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HMOX1—breast cancer	7.76e-06	0.000128	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ITPR1—breast cancer	7.74e-06	0.000128	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CG—breast cancer	7.66e-06	0.000127	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APC—breast cancer	7.66e-06	0.000127	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KIT—breast cancer	7.66e-06	0.000127	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGF—breast cancer	7.57e-06	0.000125	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCB1—breast cancer	7.45e-06	0.000123	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MAPK3—breast cancer	7.33e-06	0.000121	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TYMS—breast cancer	7.31e-06	0.000121	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NCOR1—breast cancer	7.23e-06	0.00012	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLA2G4A—breast cancer	7.23e-06	0.00012	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTM1—breast cancer	7.23e-06	0.00012	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BRAF—breast cancer	7.2e-06	0.000119	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CD—breast cancer	7.02e-06	0.000116	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1—breast cancer	7.01e-06	0.000116	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT2—breast cancer	7.01e-06	0.000116	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EGFR—breast cancer	6.98e-06	0.000115	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—breast cancer	6.93e-06	0.000115	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GPX1—breast cancer	6.92e-06	0.000114	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP1A1—breast cancer	6.85e-06	0.000113	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ERCC2—breast cancer	6.8e-06	0.000112	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CD—breast cancer	6.73e-06	0.000111	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CA—breast cancer	6.67e-06	0.00011	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SERPINE1—breast cancer	6.66e-06	0.00011	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—breast cancer	6.63e-06	0.00011	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—KRAS—breast cancer	6.59e-06	0.000109	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTHFR—breast cancer	6.39e-06	0.000106	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—breast cancer	6.36e-06	0.000105	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CB—breast cancer	6.12e-06	0.000101	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—breast cancer	6.07e-06	0.0001	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CA—breast cancer	6.05e-06	0.0001	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MDM2—breast cancer	6.03e-06	9.97e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RAF1—breast cancer	6.01e-06	9.93e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RELA—breast cancer	5.98e-06	9.89e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ERBB2—breast cancer	5.95e-06	9.83e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAV1—breast cancer	5.89e-06	9.74e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CB—breast cancer	5.87e-06	9.7e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MTOR—breast cancer	5.87e-06	9.7e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL8—breast cancer	5.64e-06	9.32e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.63e-06	9.31e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HRAS—breast cancer	5.6e-06	9.26e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN1B—breast cancer	5.51e-06	9.1e-05	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT1—breast cancer	5.45e-06	9e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CASP3—breast cancer	5.4e-06	8.92e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2—breast cancer	5.39e-06	8.91e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CG—breast cancer	5.37e-06	8.87e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—breast cancer	5.36e-06	8.86e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTEN—breast cancer	5.29e-06	8.74e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCND1—breast cancer	5.25e-06	8.68e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—JUN—breast cancer	5.24e-06	8.66e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CTNNB1—breast cancer	5.2e-06	8.6e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—breast cancer	5.1e-06	8.43e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN1A—breast cancer	5.08e-06	8.4e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTEN—breast cancer	5.07e-06	8.38e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK8—breast cancer	4.96e-06	8.2e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT1—breast cancer	4.95e-06	8.18e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CD—breast cancer	4.72e-06	7.8e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SRC—breast cancer	4.7e-06	7.77e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—breast cancer	4.66e-06	7.7e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—breast cancer	4.58e-06	7.57e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT3—breast cancer	4.53e-06	7.49e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—breast cancer	4.46e-06	7.37e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK3—breast cancer	4.33e-06	7.16e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MYC—breast cancer	4.21e-06	6.96e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFB1—breast cancer	4.2e-06	6.95e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGFR—breast cancer	4.12e-06	6.81e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CB—breast cancer	4.11e-06	6.8e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—breast cancer	4.08e-06	6.74e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KRAS—breast cancer	3.89e-06	6.43e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CA—breast cancer	3.73e-06	6.17e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CA—breast cancer	3.58e-06	5.91e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTEN—breast cancer	3.55e-06	5.88e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TP53—breast cancer	3.46e-06	5.72e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HRAS—breast cancer	3.31e-06	5.47e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—breast cancer	3.17e-06	5.24e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKT1—breast cancer	3.05e-06	5.04e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT1—breast cancer	2.92e-06	4.83e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CA—breast cancer	2.51e-06	4.14e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKT1—breast cancer	2.05e-06	3.39e-05	CbGpPWpGaD
